{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:25:41Z","timestamp":1791563141816,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1136\/ard.2010.140848","type":"journal-article","created":{"date-parts":[[2011,3,2]],"date-time":"2011-03-02T20:25:41Z","timestamp":1299097541000},"page":"982-989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"title":["Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI"],"prefix":"10.1016","volume":"70","clinical-trial-number":[{"clinical-trial-number":"nct00604539","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Lukas Martin","family":"Wildi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Raynauld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne","family":"Martel-Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Bessette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Abram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Dorais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2010.140848_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","article-title":"Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.","volume":"41","author":"Lawrence","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.140848_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0033-8389(03)00161-1","article-title":"An update on the pathogenesis and epidemiology of osteoarthritis.","volume":"42","author":"Felson","year":"2004","journal-title":"Radiol Clin North Am"},{"key":"10.1136\/ard.2010.140848_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11926-006-0019-1","article-title":"Epidemiology of osteoarthritis: an update.","volume":"8","author":"Issa","year":"2006","journal-title":"Curr Rheumatol Rep"},{"key":"10.1136\/ard.2010.140848_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthr Cartil"},{"issue":"Suppl A","key":"10.1136\/ard.2010.140848_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1063-4584(98)80011-3","article-title":"Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study.","volume":"6","author":"Uebelhart","year":"1998","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.140848_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.joca.2004.01.004","article-title":"Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo.","volume":"12","author":"Uebelhart","year":"2004","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.140848_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.20867","article-title":"Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial.","volume":"52","author":"Michel","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.140848_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/art.24255","article-title":"Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial.","volume":"60","author":"Kahan","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.140848_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","article-title":"Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.","volume":"357","author":"Reginster","year":"2001","journal-title":"Lancet"},{"key":"10.1136\/ard.2010.140848_bib10","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","article-title":"Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.","volume":"162","author":"Pavelk\u00e1","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2010.140848_bib11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.joca.2007.06.011","article-title":"Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials.","volume":"16","author":"Bruyere","year":"2008","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.140848_bib12","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO;2-T","article-title":"Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip.","volume":"44","author":"Dougados","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.140848_bib13","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/art.21122","article-title":"Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial.","volume":"52","author":"Brandt","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.140848_bib14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/ard.2008.088732","article-title":"Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI.","volume":"68","author":"Raynauld","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.140848_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1063-4584(03)00029-3","article-title":"Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic knees.","volume":"11","author":"Raynauld","year":"2003","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.140848_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.joca.2003.11.003","article-title":"Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis.","volume":"12","author":"Peterfy","year":"2004","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.140848_bib17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/ard.2004.023796","article-title":"Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging.","volume":"64","author":"Berthiaume","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.140848_bib18","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1002\/art.21373","article-title":"Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity.","volume":"52","author":"Loeuille","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"Suppl A","key":"10.1136\/ard.2010.140848_bib19","doi-asserted-by":"crossref","first-page":"A87","DOI":"10.1016\/j.joca.2006.02.028","article-title":"MRI and non-cartilaginous structures in knee osteoarthritis.","volume":"14","author":"Conaghan","year":"2006","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.140848_bib20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/ard.2006.066183","article-title":"The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston Leeds Osteoarthritis Knee Score).","volume":"67","author":"Hunter","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 3","key":"10.1136\/ard.2010.140848_bib21","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.joca.2008.06.007","article-title":"A new non-invasive method to assess synovitis severity in relation to symptoms and cartilage volume loss in knee osteoarthritis patients using MRI.","volume":"16","author":"Pelletier","year":"2008","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.140848_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.rdc.2009.08.006","article-title":"Magnetic resonance imaging-based semiquantitative and quantitative assessment in osteoarthritis.","volume":"35","author":"Roemer","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.2010.140848_bib23","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1186\/ar2543","article-title":"Analysis of the precision and sensitivity to change of different approaches to assess cartilage loss by quantitative MRI in a longitudinal multicentre clinical trial in patients with knee osteoarthritis.","volume":"10","author":"Raynauld","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.140848_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/joca.1998.0112","article-title":"Effects of chondroitin sulfate and interleukin-1 beta on human articular chondrocytes cultivated in clusters.","volume":"6","author":"Bassleer","year":"1998","journal-title":"Osteoarthr Cartil"},{"issue":"Suppl A","key":"10.1136\/ard.2010.140848_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1063-4584(98)80006-X","article-title":"Anti-inflammatory activity of chondroitin sulfate.","volume":"6","author":"Ronca","year":"1998","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.140848_bib26","first-page":"148","article-title":"Effects of chondroitin sulfate-C on articular cartilage destruction in murine collagen-induced arthritis.","volume":"50","author":"Omata","year":"2000","journal-title":"Arzneimittelforschung"},{"key":"10.1136\/ard.2010.140848_bib27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.2042-3306.2002.tb05423.x","article-title":"Inhibition of articular cartilage degradation by glucosamine-HCl and chondroitin sulphate.","author":"Orth","year":"2002","journal-title":"Equine Vet J Suppl"},{"key":"10.1136\/ard.2010.140848_bib28","first-page":"669","article-title":"Influence of polysulphated polysaccharides and hydrocortisone on the extracellular matrix metabolism of human articular chondrocytes in vitro.","volume":"20","author":"Wang","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2010.140848_bib29","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2460\/ajvr.2005.66.1870","article-title":"Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants.","volume":"66","author":"Chan","year":"2005","journal-title":"Am J Vet Res"},{"key":"10.1136\/ard.2010.140848_bib30","first-page":"1329","article-title":"Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate.","volume":"33","author":"Chan","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.140848_bib31","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/ar2325","article-title":"Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study.","volume":"9","author":"Tat","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.140848_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1742-7843.2007.00158.x","article-title":"Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes.","volume":"102","author":"Jomphe","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1136\/ard.2010.140848_bib33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/ard.2006.068882","article-title":"Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues.","volume":"67","author":"Monfort","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"8A","key":"10.1136\/ard.2010.140848_bib34","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1582-4934.2009.00826.x","article-title":"Immunomodulatory and anti-inflammatory effects of chondroitin sulphate.","volume":"13","author":"du Souich","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"Suppl 1","key":"10.1136\/ard.2010.140848_bib35","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.joca.2010.01.015","article-title":"Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review.","volume":"18","author":"Martel-Pelletier","year":"2010","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.140848_bib36","first-page":"205","article-title":"A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis.","volume":"27","author":"Leeb","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.140848_bib37","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.283.11.1469","article-title":"Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis.","volume":"283","author":"McAlindon","year":"2000","journal-title":"JAMA"},{"key":"10.1136\/ard.2010.140848_bib38","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archinte.163.13.1514","article-title":"Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis.","volume":"163","author":"Richy","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2010.140848_bib39","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1185\/03007990802434932","article-title":"The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate.","volume":"24","author":"Hochberg","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1136\/ard.2010.140848_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00296-009-0969-5","article-title":"Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis.","volume":"30","author":"Lee","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.2010.140848_bib41","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.140848_bib42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis.","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.140848_bib43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/art.20000","article-title":"Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes.","volume":"50","author":"Raynauld","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.140848_bib44","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1109\/TBME.2003.814539","article-title":"Computer-aided method for quantification of cartilage thickness and volume changes using MRI: validation study using a synthetic model.","volume":"50","author":"Kauffmann","year":"2003","journal-title":"IEEE Trans Biomed Eng"},{"key":"10.1136\/ard.2010.140848_bib45","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/ar2272","article-title":"Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study.","volume":"9","author":"Pelletier","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.140848_bib46","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/ar1875","article-title":"Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes.","volume":"8","author":"Raynauld","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.140848_bib47","doi-asserted-by":"crossref","first-page":"330","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00008","article-title":"Bone marrow edema and its relation to progression of knee osteoarthritis.","volume":"139","author":"Felson","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2010.140848_bib48","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/art.21789","article-title":"Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis.","volume":"54","author":"Hunter","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.140848_bib49","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1148\/radiol.2382050122","article-title":"Subchondral bone marrow edema in patients with degeneration of the articular cartilage of the knee joint.","volume":"238","author":"Kijowski","year":"2006","journal-title":"Radiology"},{"key":"10.1136\/ard.2010.140848_bib50","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00256-008-0504-x","article-title":"Bone marrow edema in the knee in osteoarthrosis and association with total knee arthroplasty within a three-year follow-up.","volume":"37","author":"Scher","year":"2008","journal-title":"Skeletal Radiol"},{"key":"10.1136\/ard.2010.140848_bib51","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/ard.2008.096834","article-title":"Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis.","volume":"68","author":"Roemer","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"10.1136\/ard.2010.140848_bib52","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.joca.2010.02.016","article-title":"Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration.","volume":"18","author":"Hochberg","year":"2010","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.140848_bib53","doi-asserted-by":"crossref","first-page":"c4675","DOI":"10.1136\/bmj.c4675","article-title":"Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis.","volume":"341","author":"Wandel","year":"2010","journal-title":"BMJ"},{"key":"10.1136\/ard.2010.140848_bib54","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/art.23973","article-title":"The effect of glucosamine and\/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine\/chondroitin arthritis intervention trial.","volume":"58","author":"Sawitzke","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.140848_bib55","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/gme.0b013e318198e30e","article-title":"Women have increased rates of cartilage loss and progression of cartilage defects at the knee than men: a gender study of adults without clinical knee osteoarthritis.","volume":"16","author":"Hanna","year":"2009","journal-title":"Menopause"},{"key":"10.1136\/ard.2010.140848_bib56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.semarthrit.2009.10.003","article-title":"An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis.","volume":"40","author":"Raynauld","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2010.140848_bib57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1740-8261.2007.00213.x","article-title":"MRI characteristics and histology of bone marrow lesions in dogs with experimentally induced osteoarthritis.","volume":"48","author":"Martig","year":"2007","journal-title":"Vet Radiol Ultrasound"},{"key":"10.1136\/ard.2010.140848_bib58","first-page":"129","article-title":"The effect of glycosaminoglycans and proteoglycans on lipid peroxidation.","volume":"6","author":"Albertini","year":"2000","journal-title":"Int J Mol Med"},{"key":"10.1136\/ard.2010.140848_bib59","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar748","article-title":"Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats.","volume":"5","author":"Campo","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.140848_bib60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1248\/bpb.27.47","article-title":"Effects of low molecular weight chondroitin sulfate on type II collagen-induced arthritis in DBA\/1J mice.","volume":"27","author":"Cho","year":"2004","journal-title":"Biol Pharm Bull"},{"issue":"Suppl 1","key":"10.1136\/ard.2010.140848_bib61","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.joca.2010.01.017","article-title":"Chondroitin sulfate improves synovitis in rabbits with chronic antigen-induced arthritis.","volume":"18","author":"Largo","year":"2010","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.140848_bib62","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","article-title":"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.","volume":"354","author":"Clegg","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1136\/ard.2010.140848_bib63","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.joca.2010.01.018","article-title":"Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study.","volume":"18","author":"M\u00f6ller","year":"2010","journal-title":"Osteoarthr Cartil"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724100957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724100957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2010.140848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T04:20:56Z","timestamp":1736050856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724100957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0003496724100957"],"URL":"https:\/\/doi.org\/10.1136\/ard.2010.140848","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2010.140848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}